Next Article in Journal
Correction: Tabouret et al. TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma. Cancers 2020, 12, 1935
Previous Article in Journal
BRG1 Loss Is Frequent in Lung Cancer and Transforms Lung Epithelial Cells via Transcriptional and Epigenetic Reprograming
Previous Article in Special Issue
Enhancing Patient Outcomes in Head and Neck Cancer Radiotherapy: Integration of Electronic Patient-Reported Outcomes and Artificial Intelligence-Driven Oncology Care Using Large Language Models
 
 
Article

Article Versions Notes

Cancers 2025, 17(19), 3093; https://doi.org/10.3390/cancers17193093
Action Date Notes Link
article xml file uploaded 23 September 2025 09:41 CEST Original file -
article xml uploaded. 23 September 2025 09:41 CEST Update https://www.mdpi.com/2072-6694/17/19/3093/xml
article pdf uploaded. 23 September 2025 09:41 CEST Version of Record https://www.mdpi.com/2072-6694/17/19/3093/pdf
article html file updated 23 September 2025 09:45 CEST Original file https://www.mdpi.com/2072-6694/17/19/3093/html
Back to TopTop